Thursday, August 27

Health & Wellness

The FDA has recently approved Moderna’s mRNA flu vaccine. The vaccine, known as mFLUSIVA (mRNA-1010), is designed to protect adults ages 50 years and older against seasonal flu. It is the first mRNA-based flu vaccine, using similar technology as the mRNA COVID-19 vaccine

Economy News
Top Trending